Skip to main content
. 2020 May 15;6(20):eaba1362. doi: 10.1126/sciadv.aba1362

Fig. 2. Controlled release profiles of FeCO-TPP@MSN.

Fig. 2

Acid-responsive prodrug release profiles of the FeCO-TPP@MSN nanomedicine under in vitro simulated conditions (A) and intramitochondrial ROS-responsive CO release profiles of the FeCO-TPP prodrug at different ·OH concentrations (B) are shown.